IPO

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Alector kicks off biotech IPOs after US government shutdown

The 35-day US government shutdown has not just played havoc at government-run agencies – it has had a knock-on effect on the stock market because of cutbacks at the Securities and Exchange

News

Moderna shares slide after record $604m US listing

RNA drug specialist Moderna smashed the record for an initial public offering (IPO) in the US on Friday, raising a whopping $604 million, although its shares retreated 19% after the debut.

News

Secretive Moderna could finally go public with $500m IPO

RNA medicine specialist Moderna is attempting the biggest IPO in biotech history, after applying to raise $500 million from investors.

News

DNA helix in a futuristic concept of the evolution of science and medicine.

UK biotech Orchard plans $172.5m US IPO to fund rare disease...

UK biotech Orchard Therapeutics is planning a US IPO to expand use of its Strimvelis gene therapy, and further develop its rare disease pipeline.

News

UK biotech riding on crest of VC funding wave - report

Venture capital funding for the UK biotech sector is robust following a solid start to the year, according to new data.

News

Cancer blood test firm Grail mulls IPO

Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.

Alector kicks off biotech IPOs after US government shutdown

Moderna shares slide after record $604m US listing

Secretive Moderna could finally go public with $500m IPO

UK biotech Orchard plans $172.5m US IPO to fund rare disease...

UK biotech riding on crest of VC funding wave - report

Cancer blood test firm Grail mulls IPO

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

IPO

Editor's Picks